Brain cancer vaccine trial combines custom peptides with electric fields
Disease control
Ongoing
This early-phase trial tests whether a personalized vaccine made from each patient's tumor mutations, combined with Tumor Treating Fields (a device that sends electric fields to the brain), is safe and feasible for people with newly diagnosed glioblastoma. The 13 participants rec…
Phase: PHASE1 • Sponsor: Adilia Hormigo • Aim: Disease control
Last updated Jun 26, 2026 15:26 UTC